Regulation of extracellular matrix proteins in pressure-overload cardiac hypertrophy: Effects of angiotensin converting enzyme inhibition

Journal of Hypertension

Volumn 16, Issue 9, 1998, Pages 1345-1355

  Grimm, Daniela ^a   Kromer, Eckhard P ^a   Böcker, Wolfgang ^a   Bruckschlegel, Günter ^a   Holmer, Stephan R ^a   Riegger, Günter A J ^a   Schunkert, Heribert ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Angiotensin converting enzyme inhibition; Extracellular matrix proteins; Fibrosis; Hydralazine; Left ventricular hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT; COLLAGEN TYPE 1; COLLAGEN TYPE 3; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRONECTIN; HYDRALAZINE; LAMININ; MESSENGER RNA; RAMIPRIL; SCLEROPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA STENOSIS; ARTICLE; ASCENDING AORTA; CELL SIZE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; INTERSTITIUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0031657267     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816090-00016     Document Type: Article

References (44)

1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WB. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561-1566.
2. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975; 56:56-64.
3. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hyper-trophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 1993; 73:413-423.
4. Villarreal FJ, Dillmann WH. Cardiac hypertrophy induced changes of mRNA levels for TGF-beta 1, fibronectin, and collagen. Am J Physiol 1992; 262: H1861-H1866.
5. Crabos M, Roth M, Hahn AW, Erne P. Characterization of angiotensin II receptors in cultured adult rat cardiac fibroblasts. Coupling to signaling systems and gene expression. J Clin Invest 1994; 93:2372-2378.
6. Brilla CG, Zhou G, Matsubara L, Weber KT. Collagen metabolism in cultured adult rat fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994; 26:809-820.
7. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991; 83:1771-1779.
8. Kim S, Ohta K, Hamaguchi A, Yukimura T, Miura K, Iwao H. Angiotensin II induces cardiac phenotypic modulation and remodeling in vivo in rats. Hypertension 1995; 25:1252-1259.
9. Eleftheriades EG, Durand JB, Ferguson AG, Engelmann GL, Jones SB, Samarel AM. Regulation of procollagen metabolism in the pressure-overloaded rat heart. J Clin Invest 1993; 91:1113-1122.
10. National Institute of Health. Guide for the care and use of laboratory animals. Washington, DC: NIH publication No. 85-23, revised 1985.
11. Bruckschlegel G, Holmer S, Jandeleit K, Grimm D, Muders F, Kromer EP, et al. Blockade of the renin-angiotensin system in cardiac pressure-overload hypertrophy in rats. Effects on cardiac morphology, gene expression, and survival. Hypertension 1995; 25:250-259.
12. Litwin SE, Katz SE, Weinberg EO, Lorell BH, Aurigemma GP, Douglas PS. Serial echocardiographic-Doppler assessment of left ventricular geometry and function in rat with pressure-overload hypertrophy. Chronic angiotensin-converting enzyme inhibition attenuates the transition to heart failure. Circulation 1995; 91:2642-2654.
13. Grimm D, Elsner D, Schunkert H, Bruckschlegel G, Griese DP, Muders F, et al. Contrasting functional and morphological effects of ACE inhibition on isoproterenol-induced heart failure in the rat. Cardiovasc Res 1998; 37:91-100.
14. Anversa P, Loud AV, Levicky V, Guideri G. Left ventricular failure induced by myocardial infarction. Tissue morphometry. Am J Physiol 1985; 248:H883-H889.
15. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18:5294-5299.
16. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein C, Lorell BH. Increased rat cardiac angiotensin converting enzyme activity and mRNA levels in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility and relaxation. J Clin Invest 1990; 86:1913-1920.
17. Takahashi T, Schunkert H, Isoyama S, Wie JY, Nadal-Ginard B, Grossman W, et al. Age-related differences in the expression of proto-oncogene and contractile protein genes in response to pressure-overload in the rat myocardium. J Clin Invest 1992; 89:939-946.
18. Fort P, Marty L, Piechaczyk M, Sabrouty SE, Dany C, Jaenteur P, et al. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate dehydrogenase multigenic family. Nucleic Acids Res 1985; 13:1431-1442.
19. SPSS 6.1. Syntax Reference Guide. SPSS. Inc., Addison & Wesley, Massachusetts, USA; 1994.
20. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980; 47:1-9.
21. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension. Role of interstitial fibrosis and medial thickening of intramyocardial arteries. Circ Res 1991; 69:107-115.
22. Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 1993; 27:341-348.
23. Krayenbuhl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M. Left ventricular myocardial structure in aortic valve disease before, intermediate, and late after aortic valve replacement. Circulation 1989; 79:744-755.
24. Katayama S, Abe M, Inaba M, Itabashi A, Ishii J. Effects of captopril or nitrendipine of left ventricular collagen or laminin B2 gene expression. Jpn Heart 1993; 34:773-783.
25. Boluyt MO, O'Neill L, Meredith AL, Bing OHL, Brooks WW, Conrad CH, et al. Alterations in cardiac gene expression during the transition from stable hypertrophy to heart failure. Marked upregulation of genes encoding extracellular matrix proteins. Circ Res 1994; 75:23-32.
26. Pfeffer JM, Pfeffer MA, Fishbein MC, Fröhlich ED. Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol 1979; 237:H461-H468.
27. Mirsky I, Pfeffer JM, Pfeffer MA, Braunwald E. The contractile state as a major determinant in the evolution of left ventricular dysfunction in the spontaneously hypertensive rat. Circ Res 1983; 53:767-778.
28. Schunkert H, Weinberg EO, Bruckschlegel G, Riegger GAJ, Lorell BH. Alteration of growth responses in established cardiac pressure-overload hypertrophy in rats with aortic banding. J Clin Invest 1995; 96:2768-2774.
29. Kromer EP, Elsner D, Riegger GAJ. Role of neurohumoral systems for pressure induced left ventricular hypertrophy in experimental supravalvular aortic stenosis in rats. Am J Hypertens 1991; 4:521-524.
30. Weinberg EO, Schoen FJ, George D, Kagaya Y, Douglas PS, Litwin SE, et al. Angiotensin-converting enzyme inhibition prolongs survival and modifies the transition to heart failure in rats with pressure overload hypertrophy due to ascending aortic stenosis. Circulation 1994; 90:1410-1422.
31. Farhadian F, Contard F, Corbier A, Barrieux A, Rappaport L, Samuel J. Fibronectin expression during physiological and pathological growth. J Mol Cell Physiol 1995; 27:981-990.
32. Mamuya WA, Chobanian P, Brecher P. Age-related changes in fibronectin expression in spontaneously hypertensive Wistar-Kyoto and Wistar rat hearts. Circ Res 1992; 71:1341-1350.
33. Knowlton KU, Rockman HA, Itani M, Vovan A, Seidman CE, Chien KR. Divergent pathways mediate the induction of ANF transgenes in neonatal and hypertrophic ventricular myocardium. J Clin Invest 1995; 96:1311-1318.
34. Nagasawa K, Zimmermann R, Münkel B, Linz W, Schölkens B, Schaper J. Extracellular matrix deposition in hypertensive hearts. Antifibrotic effect of ramipril. Eur Heart J 1995; 16:33-37.
35. Panizo A, Pardo J, Hernandez M, Galindo MF, Cenarruzabeitia E, Diez J. Quinapril decreases myocardial accumulation of extracellular matrix components in spontaneously hypertensive rats. Am J Hypertens 1995; 8:815-822.
36. Schunkert H, Ingelfinger JR, Hirsch AT, Tang SS, Litwin SE, Talsness CE, et al. Evidence for tissue-specific activation of renal angiotensinogen mRNA expression in chronic stable experimental heart failure. J Clin Invest 1992; 90:1523-1529.
37. Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H, et al. Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res 1993; 72:312-318.
38. Ruzicka M, Yuan B, Harmsen E, Leenen FGG. The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker. Circulation 1993; 87:921-930.
39. Iwai N, Shimoike H, Kinoshita M. Cardiac renin-angiotensin system in the hypertrophied heart. Circulation 1995; 92:2690-2696.
40. Linz W, Wiemer G, Schölkens BA. Contribution of bradykinin to the cardiovascular effects of ramipril. J Cardiovasc Pharmacol 1993; 22 (suppl 9):S1-S8.
41. Ratajska A, Campbell SE, Cleutjens JPM, Weber KT. Angiotensin II and structural remodeling in coronary vessels in rats. J Lab Clin Med 1994; 124:408-415.
42. Ratajska A, Campbell SE, Sun Y, Weber KT. Angiotensin II associated cardiac myocyte necrosis: role of adrenal catecholamines. Cardiovasc Res 1994; 28:684-690.
43. Yang CM, Kandaswamy V, Young D, Sen S. Changes in collagen phenotypes and regression of cardiac hypertrophy. Cardiovasc Res 1997; 36:236-245.
44. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone-system. Circulation 1991; 83:1849-1865.